Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean W Felsher

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
Cell Cycle (Georgetown, Tex.)|July 10, 2003
How cancers escape their oncogene habitSylvie Giuriato, Dean W Felsher
Seminars in Cancer Biology|August 29, 2006
Conditional transgenic models define how MYC initiates and maintains tumorigenesisConstadina Arvanitis, Dean W Felsher
Cancer Letters|July 26, 2005
Conditionally MYC: insights from novel transgenic modelsConstadina Arvanitis, Dean W Felsher
Trends in Molecular Medicine|June 16, 2005
Rehabilitation of cancer through oncogene inactivationCatherine M Shachaf, Dean W Felsher
Nature Cell Biology|December 23, 2009
Myc and a Cdk2 senescence switchJan van Riggelen, Dean W Felsher
Cancer Research|June 3, 2005
Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcyCatherine M Shachaf, Dean W Felsher
Cancer Research|August 1, 2020
The Myc and Ras Partnership in Cancer: Indistinguishable Alliance or Contextual Relationship?Wadie D Mahauad-Fernandez, Dean W Felsher
Cold Spring Harbor Perspectives in Medicine|June 4, 2014
MYC activation is a hallmark of cancer initiation and maintenanceMeital Gabay, Yulin Li, Dean W Felsher
Cancer Drug Resistance (Alhambra, Calif.)|January 11, 2023
Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approachLeroy Lowe, J William LaValley, Dean W Felsher
Trends in Immunology|February 25, 2017
MYC: Master Regulator of Immune PrivilegeStephanie C Casey, Virginie Baylot, Dean W Felsher
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Cell Cycle (Georgetown, Tex.)|July 10, 2003
How cancers escape their oncogene habitSylvie Giuriato, Dean W Felsher
Seminars in Cancer Biology|August 29, 2006
Conditional transgenic models define how MYC initiates and maintains tumorigenesisConstadina Arvanitis, Dean W Felsher
Cancer Letters|July 26, 2005
Conditionally MYC: insights from novel transgenic modelsConstadina Arvanitis, Dean W Felsher
Trends in Molecular Medicine|June 16, 2005
Rehabilitation of cancer through oncogene inactivationCatherine M Shachaf, Dean W Felsher
Nature Cell Biology|December 23, 2009
Myc and a Cdk2 senescence switchJan van Riggelen, Dean W Felsher
Cancer Research|June 3, 2005
Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcyCatherine M Shachaf, Dean W Felsher
Cancer Research|August 1, 2020
The Myc and Ras Partnership in Cancer: Indistinguishable Alliance or Contextual Relationship?Wadie D Mahauad-Fernandez, Dean W Felsher
Cold Spring Harbor Perspectives in Medicine|June 4, 2014
MYC activation is a hallmark of cancer initiation and maintenanceMeital Gabay, Yulin Li, Dean W Felsher
Cancer Drug Resistance (Alhambra, Calif.)|January 11, 2023
Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approachLeroy Lowe, J William LaValley, Dean W Felsher
Trends in Immunology|February 25, 2017
MYC: Master Regulator of Immune PrivilegeStephanie C Casey, Virginie Baylot, Dean W Felsher
Pageof 15